A study introduces a method to measure active and inactive enzymes in single cells. Results show protein activity often ...
The FDA accepted the BLA for ivonescimab plus chemotherapy for patients with EGFR-mutated non-small cell lung cancer post-TKI ...
Adjuvant systemic therapy was associated with improved rates of overall survival among patients who underwent surgical resection for MM.
With a 5-year survival of only 3.3% in advanced disease, pancreatic cancer remains one of the most lethal human tumors. But ...
The "Molecular Switch Targeting Therapies Market Landscape, Innovation Pipeline and Commercial Impact 2026" report has been ...
A deep-learning serial CT biomarker improves survival prediction in immunotherapy-treated NSCLC and outperforms RECIST. Find ...
Morges, Switzerland Monday, February 2, 2026, 16:00 Hrs [IST] ...
In the era of personalized oncology, implementation of reliable biomarkers with prognostic and predictive value is necessary, the latter being most ...
A centuries-old medicinal root is gaining renewed scientific attention for its ability to target multiple biological ...
The FDA grants Fast Track designation to BNT113 for treating HPV16+ head and neck squamous cell carcinoma expressing PD-L1 in the first-line setting.
Kazia stated that in murine triple-negative breast cancer preclinical models, NDL2 reduced primary tumor volume by 49% as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results